; and (bb) the amount by which the stock or other certificates of ownership interest of the person that is owned by the individual has increased in value during the period during which such person engaged in illegal marketing or distribution practices of an opioid product, without regard to whether the individual has sold any of the stock or certificates from such opioid manufacturer or distributor; and (II) with respect to a violation that occurs on or after the date of enactment of the Opioid Crisis Accountability Act of 2018 , subject to the period of imprisonment specified under section 401 of the Controlled Substances Act that would be applicable for a violation of subsection (a) of such section that involved the quantity of opioids that were involved in the illegal marketing or distribution practices with respect to an opioid; (ii) if not a natural person, shall be subject to a civil penalty in the amount equal to the sum of— (I) $7,800,000,000; plus (II) 25 percent of the total profit such person made on lawful sales of opioids in the United States during the period in which the person engaged in illegal marketing or distribution practices. (B) If a person that is not a natural person violates paragraph (2), the court, without regard to the participation of such individuals in, or knowledge of such individuals of, the violation, shall— (i) impose on the chief executive officer (or equivalent) of the person a civil penalty in an amount equal to the sum of— (I) the salary of the individual during the period in which the person engaged in illegal marketing or distribution practices and such individual served as chief executive officer; and (II) the amount by which the stock or other certificates of ownership interest of the person that is owned by the individual has increased in value during the period that the person engaged in illegal marketing or distribution practices and such individual served as chief executive officer, without regard to whether the individual has sold any of the stock or certificates